- Chorus One offers hype holders the opportunity to bet and delegate with minimal or no maximum limit.
- The strategic collaboration combines Falconx’s deep fluidity with Chorus One’s established POS system.
- A total of 1.83 million hype tokens worth more than $100 million have already been wagered through Chorus 1.
Chorus One, a facility-grade staking provider for over 60 Shoop-of-Stake (POS) blockchain, has announced a strategic partnership between the institution’s digital asset prime broker and crypto trading platform Falconx, launching a new node validator focusing on polymeric (hype) staking.
The Chorus One and Falconx partnership bets facility-grade hype on both retail and institutional investors. Chorus One has the expertise to enable facility-grade staking, and Falconx offers deep liquidity to its hype staking programme.
Chorus One’s hype staking program has already attracted 1,833,509 high lipid tokens, worth more than $100 million at the time of this report.
Why is the hype already staking the chorus for over $100 million?
The hype of the chorus grew exponentially in the short term, strengthened by its strategic partnership with Falconx. Additionally, users who are engaged in hype with Chorus One users will benefit from Falconx’s safe, compliant and capital-efficient digital asset management services.
“Chorus One supports the institution through access to the in-depth expertise of our research team on HIP-3 standards that enable us to hype our public validators, support for white label variators, reporting suites for hype, and the creation of custom biased contract markets,” the announcement noted.
Chorus One’s Hype BALIBATOR Node currently offers an annual rate of return (ARR) of around 2.26%. For example, selecting an investor with 1000 hype tokens and one validator node with a chorus will get an annual warning of $1,235.
Meanwhile, Chorus One works closely with liquid staking protocols within high lipid ecosystems, including Kinetiq and Hyperbeat. So, Chorus One offers additional profit margins for hype customers, in addition to the added value of base ARRs and tokens.
Why is the high liquid staking now?
High lipid chains have been promoted in the recent past by decentralized exchanges, allowing for seamless trading of futures and derivatives markets. About 431.5 million people were betted by different Validator Node Operators led by Chorus One in a total of 1 billion hype tokens.
Astronomical demand for decentralized derivative trading helped to surge in the total value of high lipids to more than $2.6 billion in the first year of the operation. Furthermore, the high lipid chain has grown its stable market capitalization to over $5.755 billion.
So hype prices have been recording bullish momentum since the start of official trading in late 2024, with Altcoin ralliing from $6.5 for trades over $53 within ten months.
Chorus One’s strategic launch of hype staking will work with Falconx to enhance network governance. Chorus One has a sufficient team of experts who perform node validators for the greatest profits of investors and the long-term benefits of the underlying chain.
